Intelligent Bio Solutions (INBS) EPS (Weighted Average and Diluted) (2022 - 2024)
Intelligent Bio Solutions has reported EPS (Weighted Average and Diluted) over the past 3 years, most recently at -$1.43 for Q1 2024.
- Quarterly results put EPS (Weighted Average and Diluted) at -$1.43 for Q1 2024, up 97.92% from a year ago — trailing twelve months through Mar 2024 was -$38.94 (up 74.66% YoY), and the annual figure for FY2024 was -$6.38, up 94.98%.
- EPS (Weighted Average and Diluted) for Q1 2024 was -$1.43 at Intelligent Bio Solutions, up from -$2.07 in the prior quarter.
- Over the last five years, EPS (Weighted Average and Diluted) for INBS hit a ceiling of -$1.43 in Q1 2024 and a floor of -$68.67 in Q1 2023.
- Median EPS (Weighted Average and Diluted) over the past 3 years was -$4.2 (2022), compared with a mean of -$14.7.
- Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 707.61% in 2023 and later soared 97.92% in 2024.
- Intelligent Bio Solutions' EPS (Weighted Average and Diluted) stood at -$5.56 in 2022, then surged by 62.77% to -$2.07 in 2023, then skyrocketed by 30.92% to -$1.43 in 2024.
- The last three reported values for EPS (Weighted Average and Diluted) were -$1.43 (Q1 2024), -$2.07 (Q4 2023), and -$12.48 (Q3 2023) per Business Quant data.